ArticleCancers2026

Adverse Events as a Surrogate of Sufficient Pharmacological Exposure in Metronomic Combination Chemotherapy: Extended Real-World Cohort Analysis of the FulVEC Regimen in Metastatic ER+/HER2- Breast Cancer.

Anna Buda-Nowak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.